clinical trial · NCT07541833
Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)
Bristol-Myers Squibb·—·recruiting·n = 36
CardiomyopathyMavacamten
brief summary
The purpose of this study is to assess the real-world effectiveness and safety of mavacamten in adults diagnosed with symptomatic obstructive hypertrophic cardiomyopathy (HOCM) receiving cibenzoline in Japan
started
Feb 5, 2026
primary completion
Dec 31, 2026
completion
Dec 31, 2026
last updated
Apr 21, 2026
official title
A Study Evaluating Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Cibenzoline in Japan (MANAGE-HCM)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol